AR104541A1 - Formulación de hidrogel con adhesión moderada - Google Patents
Formulación de hidrogel con adhesión moderadaInfo
- Publication number
- AR104541A1 AR104541A1 ARP160101295A ARP160101295A AR104541A1 AR 104541 A1 AR104541 A1 AR 104541A1 AR P160101295 A ARP160101295 A AR P160101295A AR P160101295 A ARP160101295 A AR P160101295A AR 104541 A1 AR104541 A1 AR 104541A1
- Authority
- AR
- Argentina
- Prior art keywords
- animal
- nipple
- hydrogel composition
- physical barrier
- hydrogel
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 7
- 210000002445 nipple Anatomy 0.000 abstract 4
- 230000004888 barrier function Effects 0.000 abstract 3
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 2
- 239000004599 antimicrobial Substances 0.000 abstract 2
- 210000000481 breast Anatomy 0.000 abstract 2
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KEQFDTJEEQKVLM-JUODUXDSSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydron;chloride Chemical group Cl.S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 KEQFDTJEEQKVLM-JUODUXDSSA-N 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 229960001356 ceftiofur hydrochloride Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Reivindicación 1: Un método de tratar un animal, el método que comprende administrar una composición de hidrogel al tejido mamario del animal. Reivindicación 11: El método de acuerdo con la reivindicación 1, donde la composición de hidrogel comprende macrómero de alcohol polivinílico hidrosoluble. Reivindicación 16: El método de acuerdo con la reivindicación 1, que además comprende administrar un agente antimicrobiano al tejido mamario del animal. Reivindicación 17: El método de acuerdo con la reivindicación 1, donde el agente antimicrobiano es clorhidrato de ceftiofur. Reivindicación 21: El método de acuerdo con la reivindicación 1, donde el método comprende formar una barrera física en un canal del pezón del animal, dicha barrera física que es efectiva para el tratamiento profiláctico de los trastornos mamarios. Reivindicación 30: Un sistema para formar una barrera física en un pezón de un animal, dicho sistema que comprende: una composición de hidrogel que comprende un macrómero de alcohol polivinílico hidrosoluble y un poliol; y un dispositivo de inyección adaptado para infundir la composición de hidrogel en una cisterna del pezón del pezón del animal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562157627P | 2015-05-06 | 2015-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104541A1 true AR104541A1 (es) | 2017-07-26 |
Family
ID=56027205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160101295A AR104541A1 (es) | 2015-05-06 | 2016-05-06 | Formulación de hidrogel con adhesión moderada |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9987362B2 (es) |
| EP (1) | EP3291820B1 (es) |
| CN (1) | CN107530277A (es) |
| AR (1) | AR104541A1 (es) |
| AU (1) | AU2016256858B2 (es) |
| BR (1) | BR112017023841B1 (es) |
| CA (2) | CA3077942C (es) |
| CL (1) | CL2017002801A1 (es) |
| ES (1) | ES2949838T3 (es) |
| MX (1) | MX370083B (es) |
| PL (1) | PL3291820T3 (es) |
| RU (1) | RU2693041C2 (es) |
| UY (1) | UY36676A (es) |
| WO (1) | WO2016179379A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018213433A1 (en) * | 2017-05-16 | 2018-11-22 | Biocure, Inc. | Hydrogel medical adhesives |
| JP2021500133A (ja) * | 2017-10-23 | 2021-01-07 | エンドーロジックス インコーポレイテッド | 管腔内デバイスおよびポリマー |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113854A (en) | 1977-01-10 | 1978-09-12 | Minnesota Mining And Manufacturing Company | Prophylactic treatment of mastitis |
| US4434181A (en) * | 1981-12-07 | 1984-02-28 | Fearing Manufacturing Co., Inc. | Teat dip |
| US5017369A (en) * | 1987-03-03 | 1991-05-21 | Marhevka Virginia C | Film-forming teat sealer for prevention of mastitis and use thereof |
| DE3934743A1 (de) | 1989-10-18 | 1991-04-25 | Eckold Vorrichtung | Verfahren zum verbinden zweier bauteile |
| TW272976B (es) | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
| US5665840A (en) | 1994-11-18 | 1997-09-09 | Novartis Corporation | Polymeric networks from water-soluble prepolymers |
| DE69629010T2 (de) | 1995-01-16 | 2004-04-15 | Baxter International Inc., Deerfield | Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen |
| TW360671B (en) | 1995-02-03 | 1999-06-11 | Novartis Ag | Process for producing mold body and the cross-linkable polymer used therein |
| NZ300602A (en) | 1995-02-03 | 1998-10-28 | Novartis Ag | Process for preparing mouldings (ie contact lenses) using cross linked polymers with bound photoinitiators in solution |
| EP0807270B1 (en) | 1995-02-03 | 1999-03-31 | Novartis AG | Crosslinked polymers containing ester or amide groups |
| AU4438696A (en) | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers |
| TW349967B (en) | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
| DE69636460T2 (de) | 1995-12-08 | 2007-03-29 | Novartis Ag | Plasmainduzierte polymere beschichtungen |
| US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
| US5819988A (en) | 1997-04-01 | 1998-10-13 | Sawhney; Ravi K. | Double-barreled syringe with detachable locking mixing tip |
| US6395289B1 (en) * | 1998-06-29 | 2002-05-28 | Hydromer, Inc. | Hydrophilic polymer blends used to prevent cow skin infections |
| DE69929071T2 (de) * | 1998-09-21 | 2006-08-17 | 21St Century Medicine Inc., Cucamonga | Verbesserte kälteschutzlösungen |
| US6652883B2 (en) | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
| JP4871476B2 (ja) | 2000-03-13 | 2012-02-08 | バイオコンパティブルズ ユーケー リミテッド | 塞栓組成物 |
| CA2402773C (en) * | 2000-03-13 | 2011-10-11 | Biocure, Inc. | Tissue bulking and coating compositions |
| US20020122771A1 (en) | 2000-09-23 | 2002-09-05 | Troy Holland | Spray hydrogel wound dressings |
| NZ531618A (en) | 2001-09-10 | 2005-03-24 | Bimeda Res & Dev Ltd | A bio-security system |
| AU2002359410A1 (en) | 2001-11-16 | 2003-06-10 | Biocure, Inc. | Methods for initiating in situ formation of hydrogels |
| CA2472188C (en) * | 2002-01-18 | 2011-06-21 | Control Delivery Systems, Inc. | Polymeric gel system for the controlled delivery of codrugs |
| US20060073216A1 (en) * | 2002-12-26 | 2006-04-06 | Solution Biosciences, Inc. | Compositions and methods for control of bovine mastitis |
| US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| JP2006521180A (ja) | 2003-03-25 | 2006-09-21 | バイオキュア・インコーポレーテッド | ヒドロゲル糸による医療装置 |
| MXPA06008769A (es) | 2004-02-02 | 2007-02-16 | Bimeda Res & Dev Ltd | Metodo y dispositivo para tratar un canal de tetilla de un animal. |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| US7235592B2 (en) * | 2004-10-12 | 2007-06-26 | Zimmer Gmbh | PVA hydrogel |
| US20070249712A1 (en) * | 2005-02-04 | 2007-10-25 | Dee Alejandro O | Peracetic teat dip |
| EP1935413A4 (en) * | 2005-10-12 | 2013-01-23 | Kowa Co | IONTOPHORESIS PREPARATION FOR TREATING BREAST CANCER AND / OR MASTITIS |
| JP2009513265A (ja) | 2005-10-26 | 2009-04-02 | バイオキュア・インコーポレーテッド | 膨潤可能な物品を有するヒドロゲル椎間板移植片 |
| US20080305149A1 (en) | 2007-06-11 | 2008-12-11 | Thomas Hirt | Mucoadhesive vesicles for drug delivery |
| EP2227212A1 (en) | 2007-12-07 | 2010-09-15 | BioCure, Inc. | Bone substitute |
| US20090253650A1 (en) * | 2008-04-03 | 2009-10-08 | Pongsamart S | Teat antiseptic prepared from polysaccharide gel with bactericidal and immuno-stimulating activity isolated from durian fruit-rind |
| EP2332587A1 (de) * | 2009-12-12 | 2011-06-15 | Bayer MaterialScience AG | Polyurethan-Dispersionen zur Versiegelung von Zitzen der Milchdrüse bei milchliefernden Tieren |
| US9232805B2 (en) * | 2010-06-29 | 2016-01-12 | Biocure, Inc. | In-situ forming hydrogel wound dressings containing antimicrobial agents |
| CN103997886B (zh) * | 2011-05-27 | 2017-07-18 | 祖雷克斯农业医药有限公司 | 处理哺乳动物乳头的方法及相关组合物 |
| GB201113606D0 (en) | 2011-08-05 | 2011-09-21 | Norbrook Lab Ltd | Dual chamber syringe |
| RU2521401C1 (ru) * | 2012-12-07 | 2014-06-27 | ГНУ Краснодарский научно-исследовательский ветеринарный институт Российская академия сельскохозяйственных наук (Краснодарский НИВИ) | Средство для профилактики мастита у дойных коров в сухостойный период |
| CN103275351A (zh) | 2013-05-27 | 2013-09-04 | 山东赛克赛斯药业科技有限公司 | 一种交联剂、交联聚合物及其制备方法与应用 |
| CN105530975B (zh) | 2013-09-16 | 2019-09-13 | 硕腾服务有限责任公司 | 用于依序输送物质的总成以及相关方法 |
-
2016
- 2016-05-05 AU AU2016256858A patent/AU2016256858B2/en active Active
- 2016-05-05 BR BR112017023841-1A patent/BR112017023841B1/pt active IP Right Grant
- 2016-05-05 PL PL16724201.5T patent/PL3291820T3/pl unknown
- 2016-05-05 WO PCT/US2016/030961 patent/WO2016179379A1/en active Application Filing
- 2016-05-05 MX MX2017014131A patent/MX370083B/es active IP Right Grant
- 2016-05-05 CN CN201680026018.6A patent/CN107530277A/zh active Pending
- 2016-05-05 CA CA3077942A patent/CA3077942C/en active Active
- 2016-05-05 RU RU2017136861A patent/RU2693041C2/ru active
- 2016-05-05 ES ES16724201T patent/ES2949838T3/es active Active
- 2016-05-05 US US15/147,530 patent/US9987362B2/en active Active
- 2016-05-05 EP EP16724201.5A patent/EP3291820B1/en active Active
- 2016-05-05 CA CA2984614A patent/CA2984614C/en active Active
- 2016-05-06 UY UY0001036676A patent/UY36676A/es not_active Application Discontinuation
- 2016-05-06 AR ARP160101295A patent/AR104541A1/es unknown
-
2017
- 2017-11-06 CL CL2017002801A patent/CL2017002801A1/es unknown
-
2018
- 2018-05-04 US US15/971,650 patent/US10449255B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017136861A (ru) | 2019-06-06 |
| CL2017002801A1 (es) | 2018-05-11 |
| EP3291820B1 (en) | 2023-05-24 |
| AU2016256858B2 (en) | 2020-10-08 |
| EP3291820A1 (en) | 2018-03-14 |
| CA3077942A1 (en) | 2016-11-10 |
| BR112017023841B1 (pt) | 2023-04-18 |
| RU2017136861A3 (es) | 2019-06-06 |
| US9987362B2 (en) | 2018-06-05 |
| MX2017014131A (es) | 2018-03-15 |
| MX370083B (es) | 2019-11-29 |
| US20160324969A1 (en) | 2016-11-10 |
| RU2693041C2 (ru) | 2019-07-01 |
| UY36676A (es) | 2016-12-30 |
| CA2984614A1 (en) | 2016-11-10 |
| BR112017023841A2 (pt) | 2018-07-31 |
| CA2984614C (en) | 2020-07-14 |
| ES2949838T3 (es) | 2023-10-03 |
| PL3291820T3 (pl) | 2023-08-21 |
| US10449255B2 (en) | 2019-10-22 |
| US20180264118A1 (en) | 2018-09-20 |
| CN107530277A (zh) | 2018-01-02 |
| AU2016256858A1 (en) | 2017-11-02 |
| WO2016179379A1 (en) | 2016-11-10 |
| CA3077942C (en) | 2022-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY36973A (es) | Compuestos poliméricos sol-gel y sus usos | |
| CL2016002372A1 (es) | Cenicriviroc para el tratamiento de la fibrosis. | |
| CL2018000706A1 (es) | Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer. | |
| CL2016002992A1 (es) | Combinación, composición y método de administración de la combinación o composición a animales | |
| EA201691193A1 (ru) | Система доставки лекарственных средств | |
| WO2018081812A3 (en) | METHODS OF PAIN MANAGEMENT USING TRANSDERMAL DEXMEDETOMIDINE DELIVERY DEVICES | |
| CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| CL2015002319A1 (es) | Dispositivo y sistema para el tratamiento de peces. | |
| AR098688A1 (es) | Métodos para minimizar el sobredesplazamiento de apuntalante en tratamientos de fracturas | |
| EP4324454A3 (en) | Cross-linking agents and associated methods | |
| BR112017011905A2 (pt) | dispositivo intrauterino, sistema e método para tratamento de cavidade uterina | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| MX2016010864A (es) | Metodo para el mantenimiento de cateteres uretrales. | |
| AR104541A1 (es) | Formulación de hidrogel con adhesión moderada | |
| CL2015002560A1 (es) | Un método para tratar infecciones, enfermedades o desordenes de la unidad ungueal, con un dispositivo para implantar una composición en una ubicación determinada y un régimen de dosificación para tratar una enfermedad o trastorno de la unidad ungueal. | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| CR20150567A (es) | Revestimientos reticulados suministrados mediante un balón | |
| CL2021003546A1 (es) | Sistema de acuicultura y tratamiento del moho del agua, la enfermedad bacteriana del agua fría, el síndrome del alevín de la trucha arcoíris y la enfermedad de columnaris | |
| Anees et al. | Clinical study for the efficacy of Unani formulation in the Management of Vaginal Discharge Associated with cervicitis (Iltehab-E-Unqur Rehm) | |
| AR103636A1 (es) | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol | |
| AR110433A1 (es) | Preparación oftalmológica | |
| UA95686U (uk) | Лікарський засіб для терапії захворювань передміхурової залози в формі супозиторія | |
| ECSP16095557A (es) | Métodos para tratar infecciones | |
| CL2020002050A1 (es) | Nemolizumab en el tratamiento de dermatitis atópica con excoriación moderada a grave | |
| UA117879U (uk) | Спосіб гормонального стимулювання самців дунайського лосося |